KPTI
Karyopharm Therapeutics Inc.Data: 2026-09-04
Quick Stats
Sep 04, 202645.8
AI Score
HOLD0.27
Volume Ratio
TBA
Next Earnings
13
+ve Days (30d)
16
-ve Days (30d)
KPTI Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
KPTI Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
KPTI Options - Sort by Max open Interest (near term)
5th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KPTI Daily Out of Money Options - Sort by Max open Interest (near term)
5th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KPTI Daily In the Money Options - Sort by Max open Interest (near term)
5th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KPTI Most Active Options by Volume(near term)
5th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KPTI Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
KPTI Stock Summary
Last updated Sep 04, 2026
KPTI is currently trading at $1.79, positioned below its 200-day moving average of $7.14, suggesting bearish momentum. The stock has a 52-week range of $1.72 to $10.99.
Technical Analysis: The 50-day moving average stands at $5.28, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 27.441, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.171, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates KPTI at 45.8/100 with a HOLD recommendation.
KPTI (Karyopharm Therapeutics Inc.) Indicators
Last updated Sep 04, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 27.441 |
| CMF (20) | -0.171 |
| ROC (10) | -8.673 |
| ADX (14) | 53.04 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.834 |
| AROONOSC (14) | -21.429 |
| WILLAMS %R (14) | -83.333 |
| MFI (14) | 57.88 |
Karyopharm Therapeutics Inc. is below both the 50 Day and 200 Day SMA which is considered Bearish.
KPTI Moving Averages Analysis
KPTI (Karyopharm Therapeutics Inc.) Simple Moving Averages
Moving Averages are last updated Sep 04, 2026
| Days | MA |
|---|---|
| 10 | 1.88 |
| 20 | 1.92 |
| 30 | 2.61 |
| 50 | 5.28 |
| 100 | 7.06 |
| 200 | 7.14 |
KPTI Fundamental Analysis
| P/E (Forward) | -- |
| P/E (Trailing) | -- |
| Market Cap ($) | 40.1 million |
| Earnings/Share ($) | -14.33 |
| Net Profit Margin (%) | -1.5328 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -5.845 |
| EPS Estimate Next Year ($) | -2.82 |
| WallStreet Target Price ($) | 7.25 |
| Most Recent Quarter |
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.